1 / 110

Weapons of Mass Destruction

Weapons of Mass Destruction. Rosen Chapt 195 May 17, 2007 Roy Seitz, M.D. slides by Scott Gunderson PGY-3. Nuclear & Radiological Events. Potential Nuclear/Radiological Hazards in the U.S. Simple Radiological Device “Dirty” Conventional Bomb Improvised Nuclear Device (IND)

roz
Download Presentation

Weapons of Mass Destruction

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Weapons of Mass Destruction Rosen Chapt 195 May 17, 2007 Roy Seitz, M.D. slides by Scott Gunderson PGY-3

  2. Nuclear & Radiological Events

  3. Potential Nuclear/Radiological Hazards in the U.S. • Simple Radiological Device • “Dirty” Conventional Bomb • Improvised Nuclear Device (IND) • 1kT “Suitcase Nuke” • Ballistic Missile Attack • 250 kT Nuclear Weapon – “City Killer”

  4. Radiation Dispersal “Dirty bombs” • Low level contamination • Acute radiation casualties are unlikely • Decontamination and clean up are main issues

  5. Texas Motor SpeedwayExercise, November 2004 Three critical gaps identified: • Casualty / Patient Triage • Medical Decontamination (Med Decon) • Personal Protective Equipment (PPE)

  6. Diversion of Nuclear Weapons • “We may have lost up to 100 one-kiloton suitcase sized nuclear bombs” • Alexander Lebed (Former) Chief, National Security, USSR

  7. Energy Partition Standard Fission / Fusion AFRRI, Medical Effects of Nuclear Weapons, “Blast and Thermal Effects” Lecture, 1990.

  8. Scenario: Washington Mall

  9. AFRRI, Medical Effects of Nuclear Weapons, “Blast and Thermal Effects” Lecture, 1990.

  10. Effective Range For Thermal Energy1 kT Weapon AFRRI, Medical Effects of Nuclear Weapons, “Blast and Thermal Effects” Lecture, 1990.

  11. AFRRI, Medical Effects of Nuclear Weapons, “Blast and Thermal Effects” Lecture, 1990.

  12. Atlanta SSE Med Wind 250Kton Fatalities

  13. Atlanta 250 kiloton SSE wind7mph

  14. New York City – 250 kT Nuclear Detonation Mortality Probability 3.9m Affected Red 90% Dark Blue 40% Lt Brown 80% Lt Purple 30% Yellow 70% Dk Purple 20% Green 60% Dk Pink 10% Pale Blue 50% Lt Pink 1%

  15. What is Fallout? • A complex mixture of over 200 different isotopes of 36 elements • 2 oz of fission products formed for each kT of yield. • Size < 1 micron to several mm.

  16. Early Fallout • Reaches the ground during the first 24 hours after detonation • Early fallout = 50-70% of total radioactivity • Highest degree of fallout risk • 7:10 Rule for estimating exposure Hours 1 7 49 Gy/hr 1 0.1 0.01

  17. Delayed Fallout • Arrives after 1st day • Very fine / invisible particles • Settle in very low concentrations over most of the earth’s surface • 40% of total radioactivity • Much lower degree of risk relative to early fallout

  18. Alpha Beta Gamma Neutron 1 m Concrete Ionizing Radiation Any Radiation Consisting of Directly or Indirectly Ionizing Particles or Photons

  19. 3 2 1 Feet Keys to Limiting Exposure • Shielding • Dense objects limit the amount of radiation that can get to you • Distance • Dose decreases rapidly as you move away from the source • Time • Minimizing time spent in proximity to the source is important 500 R/hr 125 55

  20. Radiation Injury Organ Damage Cellular Damage Chemical Damage Free Radicals 10-10 Seconds 1. Proteins 2. Membrane 3. DNA Tissue damage & Loss of organ function Hours to years Seconds to hours

  21. Distribution of Injuries in aNuclear Detonation Single Injuries (30% - 40%) Combined Injuries (65% - 70%) Data from Walker RI, Cerveny TJ Eds., Medical Consequences of Nuclear Warfare, TMM Publications, Falls Church, 1989. p 11.

  22. Hemogram(300 cGy TBI Exposure)

  23. Absolute Lymphocyte Count over 48 hours Confirms Significant Radiation Exposure Andrews Lymphocyte Nomogram From Andrews GA, Auxier JA, Lushbaugh CC: The Importance of Dosimetry to the Medical Management of Persons Exposed to High Levels of Radiation. In Personal Dosimetry for Radiation Accidents. Vienna, International Atomic Energy Agency, 1965, pp 3- 16

  24. Primary Treatment Strategy • Treat life threatening trauma first • Remove clothing / Decontaminate • Treat radiation effects • Burn care • Pharmaceutical therapies • If surgery is needed • first 1-2 days OR • 50 days post-exposure

  25. Decontamination Equipment • Hospital Surgical Gown (waterproof) • Cap, Face Shield, Booties (waterproof) • Double Gloves (inner layer taped) • Drapes • Plastic Bags • Butcher Paper • Large Garbage Cans • Radiation Signs and Tape

  26. Decon Agents • Dry Removal • Disrobing is 80% effective • Soap / Shampoo & Water • Others ??

  27. Nuclear Summary • Nuclear & Radiological Devices • Lots of trauma and burn injuries • ARS and cancers • Care Issues • Bed Capacity / Availability • Burn & Trauma care • Decontamination • Antidotes • Need for extensive planning

  28. Biological Weapons

  29. Definition of Bioterrorism Intentional use of pathogen or bacterial product to: • Cause harm to humans • Influence government conduct • Intimidate or coerce a civilian population

  30. Bioterrorism Release Types • Overt Release • Notice of release provided • May contain a threat • Designed to create panic or fear • White powder hoaxes • May be hoax or credible threat • Covert Release • No notice or threat • Difficult to detect

  31. Biological Agent Overview

  32. Bacillus anthracis Anthrax

  33. Anthrax- General • Endemic in animals worldwide with occasional human cases (usually cutaneous) • Spores used for bioattack • Aerosolized directly or sent in mail/packages • Three forms • Cutaneous, Inhalation, GI

  34. Anthrax – Clinical Features • Inhalation • Incubation: 2-43 days (may be longer) • Prodrome • fevers, malaise, dry cough, chest pain, dyspnea, myalgia • Abrupt onset of fulminant illness • Widened mediastinum, pleural effusions; meningitis in ~50% • Actual pneumonia uncommon

  35. Inhalational anthrax—US index case

  36. Anthrax – Clinical Features • Cutaneous • Incubation: 1 to 7days (may be up to 12 days) • Erythematous papule  ulcer  characteristic black eschar with surrounding erythema and edema • Regional adenopathy and systemic symptoms (e.g., fever, malaise) may develop

  37. Cutaneous Anthrax

  38. Anthrax – Clinical Features • Gastrointestinal • Incubation period 1-7 days • Not likely after a bioattack • Presents as febrile illness with bloody diarrhea

  39. Anthrax Diagnosis • Blood cultures • usually positive in <24h • Gram stain/Dx of pleural fluid or CSF • Sputum is usually NOT positive by stain/culture • Fever and widened mediastinum on CXR/CT very suggestive • Cutaneous disease • culture fluid from under eschar • Nasal swabs are a poor test

  40. Anthrax in CSF—US index case

  41. Anthrax - Treatment • Ciprofloxacin 400 mg IV q12h • 10-15 mg/kg for children • other fluoroquinolones probably also effective OR • Doxycycline 100 mg IV q12h • 2.2 mg/kg for children PLUS • 1 or 2 additional antibiotics • (clindamycin, rifampin, vancomycin, penicillin, chloramphenicol, imipenem, clarithromycin)

  42. Anthrax - Treatment • Switch to oral therapy when clinically appropriate • 60 days therapy (or until third dose vaccine) • ciprofloxacin 500 mg PO BID or • doxycycline 100 mg PO BID

  43. Prophylaxis and Infection Control • Prophylaxis • Ciprofloxacin 500 mg PO BID (10-15 mg/kg for children ) or • Doxycycline 100 mg PO BID (2.2 mg/kg for children) • Continue for 60 days (? 100 days) • Vaccine available for DOD forces • Infection Control • Standard barrier precautions are needed

  44. Vaccine 17

  45. Yersinia pestis Plague Source: www.cdc.gov Yersinia pestis

  46. Plague - General • Endemic in animals many parts of the world • Including prairie dogs in the southwestern us • High potential as a BT agent • Endemic form • Spread to humans via a flea vector • Bubonic form of the disease • Bioattack • Most likely aerosolized • Pneumonic plague

More Related